CRIS
Price
$2.46
Change
+$0.21 (+9.33%)
Updated
May 30 closing price
Capitalization
25.74M
VTGN
Price
$2.58
Change
+$0.03 (+1.18%)
Updated
May 30 closing price
Capitalization
73.6M
Interact to see
Advertisement

CRIS vs VTGN

Header iconCRIS vs VTGN Comparison
Open Charts CRIS vs VTGNBanner chart's image
Curis
Price$2.46
Change+$0.21 (+9.33%)
Volume$70.27K
Capitalization25.74M
VistaGen Therapeutics
Price$2.58
Change+$0.03 (+1.18%)
Volume$95.25K
Capitalization73.6M
CRIS vs VTGN Comparison Chart
Loading...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRIS vs. VTGN commentary
Jun 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIS is a StrongBuy and VTGN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 01, 2025
Stock price -- (CRIS: $2.46 vs. VTGN: $2.58)
Brand notoriety: CRIS and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRIS: 72% vs. VTGN: 73%
Market capitalization -- CRIS: $25.74M vs. VTGN: $73.6M
CRIS [@Biotechnology] is valued at $25.74M. VTGN’s [@Biotechnology] market capitalization is $73.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $303.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRIS’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • CRIS’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, VTGN is a better buy in the long-term than CRIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRIS’s TA Score shows that 6 TA indicator(s) are bullish while VTGN’s TA Score has 5 bullish TA indicator(s).

  • CRIS’s TA Score: 6 bullish, 4 bearish.
  • VTGN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both CRIS and VTGN are a good buy in the short-term.

Price Growth

CRIS (@Biotechnology) experienced а +23.00% price change this week, while VTGN (@Biotechnology) price change was +7.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.39%. For the same industry, the average monthly price growth was +0.48%, and the average quarterly price growth was -5.03%.

Reported Earning Dates

CRIS is expected to report earnings on Mar 31, 2025.

VTGN is expected to report earnings on Aug 10, 2023.

Industries' Descriptions

@Biotechnology (+1.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTGN($73.6M) has a higher market cap than CRIS($25.7M). VTGN YTD gains are higher at: -12.542 vs. CRIS (-19.608). CRIS has higher annual earnings (EBITDA): -44.56M vs. VTGN (-52.22M). VTGN has more cash in the bank: 88.6M vs. CRIS (20.9M). VTGN has less debt than CRIS: VTGN (1.71M) vs CRIS (3.26M). CRIS has higher revenues than VTGN: CRIS (10.3M) vs VTGN (698K).
CRISVTGNCRIS / VTGN
Capitalization25.7M73.6M35%
EBITDA-44.56M-52.22M85%
Gain YTD-19.608-12.542156%
P/E RatioN/AN/A-
Revenue10.3M698K1,476%
Total Cash20.9M88.6M24%
Total Debt3.26M1.71M190%
FUNDAMENTALS RATINGS
CRIS vs VTGN: Fundamental Ratings
CRIS
VTGN
OUTLOOK RATING
1..100
846
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
46
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9994
PRICE GROWTH RATING
1..100
6459
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (46) in the Biotechnology industry is in the same range as CRIS (63). This means that VTGN’s stock grew similarly to CRIS’s over the last 12 months.

VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CRIS (100). This means that VTGN’s stock grew similarly to CRIS’s over the last 12 months.

VTGN's SMR Rating (94) in the Biotechnology industry is in the same range as CRIS (99). This means that VTGN’s stock grew similarly to CRIS’s over the last 12 months.

VTGN's Price Growth Rating (59) in the Biotechnology industry is in the same range as CRIS (64). This means that VTGN’s stock grew similarly to CRIS’s over the last 12 months.

VTGN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CRIS (100). This means that VTGN’s stock grew similarly to CRIS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRISVTGN
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 25 days ago
89%
Bearish Trend 26 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SAP302.865.93
+2.00%
SAP SE
PED0.64N/A
+0.53%
PEDEVCO Corp
SKYT9.04-0.02
-0.22%
SkyWater Technology
PLAB16.71-0.72
-4.13%
Photronics
FUTU101.93-5.43
-5.06%
Futu Holdings Limited

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with ABOS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
+1.18%
ABOS - VTGN
48%
Loosely correlated
-2.86%
KYMR - VTGN
48%
Loosely correlated
-2.02%
ATAI - VTGN
45%
Loosely correlated
-0.43%
ZYME - VTGN
44%
Loosely correlated
+0.70%
CRSP - VTGN
42%
Loosely correlated
-1.33%
More